Repeat Cytoreductive Surgery with Hyperthermic Intraperitoneal Chemotherapy for Cancers with Peritoneal Metastasis: A 30-year Institutional Experience.

Cristian D ValenzuelaEdward A LevineChristopher W MangieriRohin GawdiOmeed MoavenGregory RussellMegan E LundyKathleen C PerryKonstantinos I VotanopoulosPerry Shen

Published in: Annals of surgical oncology (2022)

Performing multiple CRS-HIPEC operations on appropriate surgical candidates may significantly prolong survival. Appendix cancers derived the greatest benefit. Satisfactory resection margins and complication rates are comparable to first cases and achievable in repeat CRS-HIPEC procedures.

Keyphrases

minimally invasive
coronary artery bypass
locally advanced
free survival
radiation therapy
squamous cell carcinoma
metastatic renal cell carcinoma
percutaneous coronary intervention
young adults
chemotherapy induced